Press releases

  13/07/2020 08:00
|

Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension

  06/05/2020 18:00
|

Quantum Genomics Announces Interim Analysis from Study of Firibastat in Renal Failure Patients

  07/04/2020 18:00
|

Quantum Genomics Provides Update on the Impact of the COVID-19 Health Crisis on Clinical Research Activities

  26/03/2020 18:15
|

Quantum Genomics Secured New Financing, Published its Financial Statements for Fiscal Year 2019 and Provides 2019 Highlights

  28/01/2020 07:30
|

Quantum Genomics Appoints Benoît Gueugnon as Vice President of Finance

  15/01/2020 18:00
|

Quantum Genomics to Present at the Gordon Research Conference 2020 Dedicated to the Renin Angiotensin Aldosterone System